&Robin Science

Clinical trial engagement

Turning participation
into partnership

Recruiting and retaining participants is the biggest challenge in clinical research – and the costliest. Timelines slip, data suffers, and value is lost. At &Robin Science, we help sponsors overcome this trust deficit by building authentic connections with patients, caregivers, and clinicians.

Through insight, inclusivity, strategy, and storytelling, we engage the right people, guide them through consent with confidence, and support them to stay the course – delivering stronger trials, more representative data, and lasting relationships beyond a single study.

The scale of the challenge

  • 80% of clinical trials fail to reach target enrolment on time. 1
  • 9 out of 10 trials take twice as long as planned to meet enrolment goals. 2
  • On average, 30% of participants drop out after enrolling. 3
  • Recruiting each new patient costs around $6,500; replacing a dropout costs nearly $19,000. 4
  • Clinical trial delays can cost sponsors between $600,000 and $8 million per day. 5

Why it’s getting harder

Not only are there more clinical trials launched each year, precision medicines are narrowing eligibility and shrinking participant pools. Workforce shortages at research sites, competing digital noise, and declining public trust make it harder than ever to find, engage, and retain participants.

Activate –
Internal trial communication

When it comes to global clinical trials running trial sites in several countries, a strong relationship between global clinical teams and local affiliates is essential. Our internal ACTIVATE package goes beyond just delivering toolboxes. It ensures local affiliates are motivated, equipped and capable of building relationships and driving trust. It ensures affiliate teams are invested in the collaboration and the trial outcomes.

Bespoke packages for trial engagement


Awaken

Maximising top-of-funnel awareness, and equipping participating sites to spread the word, turns potential participants into engaged prospects. Our AWAKEN package delivers an agile communication plan that differentiates from competing trials, resonates across mindsets and demographics and drives inclusivity in the trial mission.

Bridge

Up to 80% of patients say their doctor’s opinion is the deciding factor in joining a trial. BRIDGE empowers community clinicians with the information, tools, and motivation they need to advocate and refer. By targeting the trial ambassadors within hard-to-reach communities, BRIDGE helps achieve diverse and representative recruitment.

Commit

Consent is a deeply sensitive touchpoint reliant on the ability to contextualise science, while accommodating different learning styles and minimising information overload. COMMIT streamlines and humanises the informed consent process, helps site teams navigate critical conversations and manage expectations, and guides patients from reflection to decision.

Defend

Enrolled participants are the most valuable, which is why DEFEND is laser-focused on sustaining commitment and minimising dropout, even for placebo patients. DEFEND proactively targets and mitigates specific retention risk points with practical, ethically compliant strategies that ensure participants feel valued, and that help site teams identify and support potential dropouts.

Read more about our scientific and medical
engagement offering

References:

  1. Brøgger-Mikkelsen M, et al J Med Internet Res. 2020;22(11):e22179.
  2. https://www.antidote.me/blog/25-useful-clinical-trial-recruitment-statistics-for-better-results
  3. https://mdgroup.com/blog/the-true-cost-of-patient-drop-outs-in-clinical-trials
  4. Moore, TJ et al. JAMA Intern Med 2018;178(11):1451-1457.
  5. Woodcock J et al. N Engl J Med 2021; 385:1351-1353.

LinkedIn
Instagram
Facebook